CGT

North Texas’ McKesson Launches InspiroGene to Support Commercialization of Cell and Gene Therapies

by | Oct 1, 2024
McKesson said that with a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape—ensuring that "patients can access the life-changing treatments they need."
MORE